VBI (4170.TWO)
TWD 13.05
(0.38%)
TWD 13.05
(0.38%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -16.13 Million TWD | 34.76% |
| 2022 | -29.56 Million TWD | 30.27% |
| 2021 | -42.39 Million TWD | 30.43% |
| 2020 | -60.92 Million TWD | 38.81% |
| 2019 | -99.57 Million TWD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -7.6 Million TWD | 0.0% |
| 2024 Q1 | -7.6 Million TWD | -56.44% |
| 2023 Q4 | -4.86 Million TWD | 0.0% |
| 2023 Q2 | -3.2 Million TWD | 0.0% |
| 2023 FY | -19.28 Million TWD | 34.76% |
| 2023 Q1 | -3.2 Million TWD | 53.39% |
| 2023 Q3 | -4.86 Million TWD | -51.87% |
| 2022 Q3 | -6.87 Million TWD | 0.0% |
| 2022 FY | -29.56 Million TWD | 30.27% |
| 2022 Q4 | -6.87 Million TWD | 0.0% |
| 2021 FY | -42.39 Million TWD | 30.43% |
| 2020 FY | -60.92 Million TWD | 38.81% |
| 2019 FY | -99.57 Million TWD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 281.85 Million TWD | 105.724% |
| Level Biotechnology Inc. | 67.55 Million TWD | 123.881% |
| TaiMed Biologics Inc. | -166.23 Million TWD | 90.295% |
| GlycoNex Incorporation | -259.86 Million TWD | 93.792% |
| GeneReach Biotechnology Corp. | -229.28 Million TWD | 92.964% |
| OBI Pharma, Inc. | -2.08 Billion TWD | 99.228% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -2.25 Million TWD | -616.023% |
| Genomics BioSci & Tech. Co.,Ltd. | -84.99 Million TWD | 81.02% |
| Visgeneer Inc. | -21.15 Million TWD | 23.758% |
| Neith Corporation | -48.85 Million TWD | 66.979% |
| Lumosa Therapeutics Co., Ltd. | -375.62 Million TWD | 95.705% |
| Medigen Vaccine Biologics Corporation | -1.21 Billion TWD | 98.671% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.61 Million TWD | -144.054% |
| Enimmune corporation | -243.47 Million TWD | 93.374% |
| TaiRx, Inc. | -214.69 Million TWD | 92.486% |
| CHO Pharma, Inc. | -268.99 Million TWD | 94.003% |
| BioLASCO Taiwan Co., Ltd. | 63.33 Million TWD | 125.471% |
| Sunny Pharmtech Inc. | -72.09 Million TWD | 77.624% |
| Ever Supreme Bio Technology Co., Ltd | 337.73 Million TWD | 104.777% |
| Feng Chi Biotech Corp. | 24.16 Million TWD | 166.766% |
| Lukas Biomedical Inc. | -43.56 Million TWD | 62.966% |
| RBC Bioscience Corporation | 14.53 Million TWD | 210.957% |
| NaviFUS Corp. | -76.42 Million TWD | 78.892% |
| BRIM Biotechnology, Inc. | -694.12 Million TWD | 97.676% |
| Shine-On BioMedical Co.,Ltd. | -62.68 Million TWD | 74.264% |
| Great Novel Therapeutics Biotech & Medicals | -65.81 Million TWD | 75.491% |
| Sagittarius Life Science Corp | -64.37 Million TWD | 74.941% |
| Bio Preventive Medicine Corp. | -70.58 Million TWD | 77.144% |
| Advagene Biopharma Co., Ltd. | -93.33 Million TWD | 82.716% |
| BioGend Therapeutics Co., Ltd. | -176.54 Million TWD | 90.862% |
| G&E Herbal Biotechnology Co., Ltd. | 80.68 Million TWD | 119.994% |
| Andros Pharmaceuticals Co.,Ltd | -67.69 Million TWD | 76.17% |
| Lin BioScience, Inc. | -1.09 Billion TWD | 98.529% |
| Anti-Microbial Savior BioteQ Co., Ltd | -56.74 Million TWD | 71.573% |
| AP Biosciences Inc | -347.47 Million TWD | 95.357% |
| Sunmax Biotechnology Co., Ltd. | 894.79 Million TWD | 101.803% |
| Syngen Biotech Co.,Ltd. | 334.08 Million TWD | 104.829% |
| EirGenix Inc. | -1.03 Billion TWD | 98.437% |
| Pharmosa Biopharm Inc. | -2.82 Million TWD | -471.246% |
| Mycenax Biotech Inc. | -602.1 Million TWD | 97.321% |
| SynCore Biotechnology Co.,Ltd | -45.5 Million TWD | 64.547% |
| Eusol Biotech Co.,Ltd. | -41.48 Million TWD | 61.111% |
| NeoCore Technology Co., Ltd. | -84.94 Million TWD | 81.009% |
| BiOptic Inc. | 44.05 Million TWD | 136.62% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -93.95 Million TWD | 82.83% |
| Sinew Pharma Inc. | -186.25 Million TWD | 91.339% |
| Greenyn Biotechnology Co., Ltd | 159.81 Million TWD | 110.094% |
| Medigen Biotechnology Corp. | -1.23 Billion TWD | 98.692% |
| 3D Global Biotech Inc. | -62.85 Million TWD | 74.334% |
| Intech Biopharm Corporation | -304.39 Million TWD | 94.7% |
| Oneness Biotech Co., Ltd. | -1.09 Billion TWD | 98.529% |
| TWi Biotechnology, Inc. | -169.55 Million TWD | 90.486% |
| TCI GENE Inc. | 10.04 Million TWD | 260.533% |
| MegaPro Biomedical Co., Ltd | -127.25 Million TWD | 87.323% |
| Senhwa Biosciences, Inc. | -311.11 Million TWD | 94.815% |
| Taiwan Bio Therapeutics Co., Ltd | -212.2 Million TWD | 92.398% |
| NatureWise Biotech & Medicals Corporation | 3.43 Million TWD | 569.773% |
| PharmaEngine, Inc. | 277.18 Million TWD | 105.82% |
| Savior Lifetec Corporation | -2.42 Million TWD | -566.612% |
| TaiGen Biopharmaceuticals Holdings Limited | -174.69 Million TWD | 90.766% |
| Meribank Biotech Co., Ltd | -123.15 Million TWD | 86.901% |
| Acepodia, Inc. | -435.97 Million TWD | 96.3% |
| Caliway Biopharmaceuticals Co., Ltd. | -487.95 Million TWD | 96.694% |